Parabolic Drugs Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
1,001
- Latest Deal Type
-
M&A
- Financing Rounds
-
5
Parabolic Drugs General Information
Description
Developer of active pharmaceutical ingredients intended to supply finished formulations, for both generic and Innovator companies across the globe. The company is engaged in manufacturing and sales, custom research and manufacturing services to global pharmaceutical companies. Its products cover the segments of semi-synthetic penicillins, cephalosporins, non-antibiotics and intermediates.
Contact Information
Website
www.parabolicdrugs.com(Operating Subsidiary)
Corporate Office
- S.C.O. 186-187, Second Floor, Sector 8-C
- Chandigarh, Punjab 160008
- India
Corporate Office
- S.C.O. 186-187, Second Floor, Sector 8-C
- Chandigarh, Punjab 160008
- India
Parabolic Drugs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Parabolic Drugs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Parabolic Drugs Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Parabolic Drugs FAQs
-
When was Parabolic Drugs founded?
Parabolic Drugs was founded in 1996.
-
Where is Parabolic Drugs headquartered?
Parabolic Drugs is headquartered in Chandigarh, India.
-
What is the size of Parabolic Drugs?
Parabolic Drugs has 1,001 total employees.
-
What industry is Parabolic Drugs in?
Parabolic Drugs’s primary industry is Pharmaceuticals.
-
Is Parabolic Drugs a private or public company?
Parabolic Drugs is a Private company.
-
What is Parabolic Drugs’s current revenue?
The current revenue for Parabolic Drugs is .
-
How much funding has Parabolic Drugs raised over time?
Parabolic Drugs has raised $46.8M.
-
Who are Parabolic Drugs’s investors?
Alden Global Capital, BTS Investment Advisors, and EQ India Advisors have invested in Parabolic Drugs.
-
When was Parabolic Drugs acquired?
Parabolic Drugs was acquired on 01-Apr-2019.
-
Who acquired Parabolic Drugs?
Parabolic Drugs was acquired by Akums Drugs and Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
